Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib

Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib

IntroductionImmune therapy has ushered in a new era of tumor treatment, at the expense of immune-related adverse events, including rare but fatal adverse cardiovascular events, such as myocarditis. Steroids remain the cornerstone of therapy for immune-related myocarditis, with no clear consensus on...

Full description

Bibliographic Details
Main Authors: Qian Xing, Zhongwei Zhang, Biao Zhu, Qionghua Lin, Lihua Shen, Fangfang Li, Zhili Xia, Zhiyong Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
myocarditis
steroid-refractory
immunosuppression
tofacitinib
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.944013/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.944013/full

Similar Items